The PBF-based dysferlin assay is a rapid and cost-effective screening tool for dysferlinopathy that requires strict adherence to sample collection and storage protocols for reliability.
Answers are grounded in this paper and cite their sources.
Requires strict sample protocols for clinical dysferlinopathy screening; extends rapid testing access but leaves reliability open pending standardization research.
The PBF-based dysferlin assay is a rapid, cost-effective and minimally invasive screening tool, well-suited for use in resource-limited settings. It provides a viable approach for initial screening and variant assessment. As the assay's reliability is influenced by sample quality and storage conditions, proper training in collection techniques and strict adherence to storage protocols are essential for ensuring diagnostic accuracy and enabling broader clinical application.
No takes yet. Share an insight, caveat, or question.
D'Este et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: